Inhibitory Effects of Trypanosoma cruzi Sialoglycoproteins on CD4+ T Cells Are Associated with Increased Susceptibility to Infection

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Nunes, Marise Pinheiro ^a   Fortes, Bárbara ^b   Silva Filho, João Luiz ^b   Terra Granado, Eugênia ^c   Santos, Leonardo ^a   Conde, Luciana ^a   de Araújo Oliveira, Isadora ^b   Freire de Lima, Leonardo ^b   Martins, Marina Vieira ^a   Pinheiro, Ana Acacia Sá ^b   Takyia, Christina Maeda ^b   Freire de Lima, Célio Geraldo ^b   Todeschini, Adriane Regina ^b   DosReis, George Alexandre ^b   Morrot, Alexandre ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; GAMMA INTERFERON; MUCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CELL EXPANSION; CELLULAR IMMUNITY; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; G1 PHASE CELL CYCLE CHECKPOINT; HEART INJURY; INFECTION SENSITIVITY; LYMPHOCYTE PROLIFERATION; MALE; MITOSIS INHIBITION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PARASITEMIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CHAGAS DISEASE; DISEASE SUSCEPTIBILITY; G1 PHASE; INTERFERON-GAMMA; INTERLEUKIN-2; MALE; MICE; MICE, INBRED BALB C; MUCINS; SIALOGLYCOPROTEINS; TRYPANOSOMA CRUZI;

EID: 84886635559     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077568     Document Type: Article

References (65)

1. Ribeiro AL, Nunes MP, Teixeira MM, Rocha MO, (2012) Diagnosis and management of Chagas disease and cardiomyopathy. Nat Rev Cardiol. 9: 576-89.
2. Barry MA, Weatherhead JE, Hotez PJ, Woc-Colburn L, (2013) Childhood parasitic infections endemic to the United States. Pediatr Clin North Am. 60: 471-85.
3. Garcia ES, Genta FA, de Azambuja P, Schaub GA, (2010) Interactions between intestinal compounds of triatomines and Trypanosoma cruzi. Trends Parasitol 26: 499-505.
4. Junqueira C, Caetano B, Bartholomeu DC, Melo MB, Ropert C, et al. (2010) The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease. Expert Rev Mol Med 15: 12-29.
5. Rosenberg CS, Martin DL, Tarleton RL, (2010) CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance. J Immunol 185: 560-8.
6. Fiuza JA, Fujiwara RT, Gomes JA, Rocha MO, Chaves AT, et al. (2009) Profile of central and effector memory T cells in the progression of chronic human chagas disease. PLoS Negl Trop Dis. 9: 512.
7. Prata A, (2001) Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1: 92-100.
8. Tarleton RL, Zhang L, (1999) Chagas disease etiology: autoimmunity or parasite persistence? Parasitol Today 15: 94-9.
9. Tarleton RL (2001) Parasite persistence in the aetiology of Chagas disease. Int J Parasitol 3: 550-4. Review.
10. Tarleton RL, (2003) Chagas disease: a role for autoimmunity? Trends Parasitol 19: 447-51.
11. Fernandes MC, Andrews NW, (2012) Host cell invasion by Trypanosoma cruzi: a unique strategy that promotes persistence. Microbiol Rev 36: 734-47.
12. Nagajyothi F, Machado FS, Burleigh BA, Jelicks LA, Scherer PE, et al. (2012) Mechanisms of Trypanosoma cruzi persistence in Chagas disease. Cell Microbiol 14: 634-43.
13. Gutierrez FR, Guedes PM, Gazzinelli RT, Silva JS, (2009) The role of parasite persistence in pathogenesis of Chagas heart disease. Parasite Immunol 31: 673-85.
14. Alcaide P, Fresno M, (2004) The Trypanosoma cruzi membrane mucin AgC10 inhibits T cell activation and IL-2 transcription through L-selectin. Int Immunol 16: 1365-75.
15. Kierszenbaum F, de Diego JL, Fresno M, Sztein MB, (1999) Inhibitory effects of the Trypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes. Eur J Immunol 29: 1684-91.
16. Kierszenbaum F, Fresno M, Sztein MB, (2002) The Trypanosoma cruzi membrane glycoprotein AGC10 inhibits human lymphocyte activation by a mechanism preceding translation of both, interleukin-2 and its high-affinity receptor subunits. Mol Biochem Parasitol 125: 91-101.
17. Van Overtvelt L, Andrieu M, Verhasselt V, Connan F, Choppin J, et al. (2002) Trypanosoma cruzi down-regulates lipopolysaccharide-induced MHC class I on human dendritic cells and impairs antigen presentation to specific CD8(+) T lymphocytes. Int Immunol 14: 1135-44.
18. Liew FY, Scott MT, Liu DS, Croft SL, (1987) Suppressive substance produced by T cells from mice chronically infected with Trypanosoma cruzi. I. Preferential inhibition of the induction of delayed-type hypersensitivity. J Immunol 139: 2452-7.
19. Padilla AM, Simpson LJ, Tarleton RL, (2009) Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection. J Immunol 183: 1245-52.
20. DosReis GA, Freire-de-Lima CG, Nunes MP, Lopes MF, (2005) The importance of aberrant T-cell responses in Chagas disease. Trends Parasitol 2: 237-43.
21. Talvani A, Coutinho SF, Barcelos Lda S, Teixeira MM, (2009) Cyclic AMP decreases the production of NO and CCL2 by macrophages stimulated with Trypanosoma cruzi GPI-mucins. Parasitol Res 104: 1141-8.
22. Campos MA, Closel M, Valente EP, Cardoso JE, Akira S, et al. (2004) Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. J Immunol 172: 1711-8.
23. Pereira-Chioccola VL, Acosta-Serrano A, Correia de Almeida I, Ferguson MA, Souto-Padron T, et al. (2000) Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies. J Cell Sci 113: 1299-307.
24. Camargo MM, Andrade AC, Almeida IC, Travassos LR, Gazzinelli RT, (1997) Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages. J Immunol 159: 6131-9.
25. Di Noia JM, Sánchez DO, Frasch AC, (1995) The protozoan Trypanosoma cruzi has a family of genes resembling the mucin genes of mammalian cells. J Biol Chem 270: 24146-9.
26. Mendonça-Previato L, Penha L, Garcez TC, Jones C, Previato JO (2013) Addition of α-O-GlcNAc to threonine residues define the post-translational modification of mucin-like molecules in Trypanosoma cruzi. Glycoconj J Feb 21.
27. Schenkman S, Eichinger D, Pereira ME, Nussenzweig V, (1994) Structural and functional properties of Trypanosoma trans-sialidase. Annu Rev Microbiol 48: 499-523.
28. Giorgi ME, de Lederkremer RM, (2011) Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite. Carbohydr Res 346: 1389-93.
29. Schenkman S, Jiang MS, Hart GW, Nussenzweig V, (1991) A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells. Cell 65: 1117-25.
30. Previato JO, Jones C, Xavier MT, Wait R, Travassos LR, et al. (1995) Structural characterization of the major glycosylphosphatidylinositol membrane-anchored glycoprotein from epimastigote forms of Trypanosoma cruzi Y-strain. J Biol Chem 270: 7241-50.
31. Nardy AF, Luiz da Silva Filho J, Pérez AR, de Meis J, Farias-de-Oliveira DA, et al. (2013) Trans-sialidase from Trypanosoma cruzi enhances the adhesion properties and fibronectin-driven migration of thymocytes. Microbes Infect 15: 365-74.
32. Mucci J, Risso MG, Leguizamón MS, Frasch AC, Campetella O, (2006) The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation. Cell Microbiol 8: 1086-95.
33. Erdmann H, Steeg C, Koch-Nolte F, Fleischer B, Jacobs T, (2009) Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E). Cell Microbiol 11: 1600-11.
34. Chuenkova M, Pereira ME, (1995) Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease. J Exp Med 181: 1693-703.
35. Muiá RP, Yu H, Prescher JA, Hellman U, Chen X, et al. (2010) Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation. Glycobiology. 20: 833-42.
36. Bermejo DA, Jackson SW, Gorosito-Serran M, Acosta-Rodriguez EV, Amezcua-Vesely MC, et al. (2013) Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells. Nat Immunol 14: 514-22.
37. Jacobs T, Erdmann H, Fleischer B, (2010) Molecular interaction of Siglecs (sialic acid-binding Ig-like lectins) with sialylated ligands on Trypanosoma cruzi. Eur J Cell Biol 89: 113-6.
38. Varki A, Gagneux P, (2012) Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci 1253: 16-36.
39. Crocker PR, Paulson JC, Varki A, (2007) Siglecs and their roles in the immune system. Nat Rev Immunol 7: 255-66.
40. Pillai S, Netravali IA, Cariappa A, Mattoo H, (2012) Siglecs and immune regulation. Annu Rev Immunol 30: 357-92.
41. Zhang JQ, Biedermann B, Nitschke L, Crocker PR, (2004) The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils. Eur J Immunol 34: 1175-84.
42. Yu Z, Maoui M, Wu L, Banville D, Shen S, (2001) mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2. Biochem J 353: 483-92.
43. Contreras VT, Salles JM, Thomas N, Morel CM, Goldenberg S, (1985) In vitro differentiation of Trypanosoma cruzi under chemically defined conditions. Mol Biochem Parasitol 16: 315-2.
44. Marks DC, Belov L, Davey MW, Davey RA, Kidman AD, (1992) The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cells. Leuk Res 16: 1165-73.
45. Charvet C, Canonigo AJ, Bécart S, Maurer U, Miletic AV, et al. (2006) Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression. J Immunol 177: 5024-31.
46. Sawai CM, Freund J, Oh P, Ndiaye-Lobry D, Bretz JC, et al. (2012) Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia. Cancer Cell 22: 452-65.
47. Jatzek A, Tejera MM, Singh A, Sullivan JA, Plisch EH, et al. (2012) p27(Kip1) negatively regulates the magnitude and persistence of CD4 T cell memory. J Immunol 189: 5119-28.
48. Kipnis TL, David JR, Alper CA, Sher A, da Silva WD, (1991) Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages. Proc Natl Acad Sci U S A 78: 602-5.
49. Joiner K, Sher A, Gaither T, Hammer C, (1986) Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B. Proc Natl Acad Sci U S A. 83: 6593-7.
50. Gazzinelli RT, Pereira ME, Romanha A, Gazzinelli G, Brener Z, (1991) Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies. Parasite Immunol 13: 345-56.
51. Anandkumar A, Devaraj H (2013) Tumor Immunomodulation: Mucins in resistance to initiation and maturation of immune response against tumors. Scand J Immunol Jan 9.
52. Allavena P, Chieppa M, Bianchi G, Solinas G, Fabbri M, et al. (2010) Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages. Clin Dev Immunol 547179.
53. Freire T, Lo-Man R, Bay S, Leclerc C, (2011) Tn glycosylation of the MUC6 protein modulates its immunogenicity and promotes the induction of Th17-biased T cell responses. J Biol Chem 11: 7797-811.
54. Ohta M, Ishida A, Toda M, Akita K, Inoue M, et al. (2010) Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9. Biochem Biophys Res Commun 402: 663-9.
55. Tinder TL, Subramani DB, Basu GD, Bradley JM, Schettini J, et al. (2008) MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma. J Immunol 181: 3116-25.
56. Pinazo MJ, Espinosa G, Cortes-Lletget C, Posada Ede J, Aldasoro E, et al. (2013) Immunosuppression and Chagas disease: a management challenge. PLoS Negl Trop Dis 7: e1965.
57. Cuervo H, Guerrero NA, Carbajosa S, Beschin A, De Baetselier P, et al. (2011) Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection. J Immunol 187: 2656-65.
58. de Araújo FF, Vitelli-Avelar DM, Teixeira-Carvalho A, Antas PR, Assis Silva Gomes J, et al. (2011) Regulatory T cells phenotype in different clinical forms of Chagas' disease. PLoS Negl Trop Dis 5: e992.
59. Alba Soto CD, Mirkin GA, Solana ME, González Cappa SM, (2003) Trypanosoma cruzi infection modulates in vivo expression of major histocompatibility complex class II molecules on antigen-presenting cells and T-cell stimulatory activity of dendritic cells in a strain-dependent manner. Infect Immun 71: 1194-9.
60. Zuñiga E, Motran C, Montes CL, Diaz FL, Bocco JL, et al. (2000) Trypanosoma cruzi-induced immunosuppression: B cells undergo spontaneous apoptosis and lipopolysaccharide (LPS) arrests their proliferation during acute infection. Clin Exp Immunol. 119: 507-15.
61. Majumder S, Kierszenbaum F, (1996) Mechanisms of Trypanosoma cruzi-induced down-regulation of lymphocyte function. Inhibition of transcription and expression of IL-2 receptor gamma (p64IL-2R) and beta (p70IL-2R) chain molecules in activated normal human lymphocytes. J Immunol 156: 3866-74.
62. Lopes MF, DosReis GA, (1996) Trypanosoma cruzi-induced immunosuppression: selective triggering of CD4+ T-cell death by the T-cell receptor-CD3 pathway and not by the CD69 or Ly-6 activation pathway. Infect Immun 64: 1559-64.
63. Abrahamsohn IA, Coffman RL, (1995) Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J Immunol 155: 3955-63.
64. Soong L, Tarleton RL, (1992) Selective suppressive effects of Trypanosoma cruzi infection on IL-2, c-myc, and c-fos gene expression. J Immunol 149: 2095-102.
65. Carlin AF, Uchiyama S, Chang YC, Lewis AL, Nizet V, et al. (2009) Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 113: 3333-6.